A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma
2019 · Journal of Neuro-Oncology · 49 citations
https://doi.org/10.1007/s11060-019-03337-2